Optimized Bio Consulting

Optimized Bio ConsultingOptimized Bio ConsultingOptimized Bio Consulting

Optimized Bio Consulting

Optimized Bio ConsultingOptimized Bio ConsultingOptimized Bio Consulting
  • Home
  • WHAT WE DO
  • GLPs
    • GLP-2, Tirzepatide
    • GLP-3, Retatrutide
  • Peptide Research
    • BPC-157
    • TB-500
    • Ipamorelin
    • Semorelin
    • Tesamorelin
    • CJC-1295 no DAC
    • MOTS-C
    • Semax
    • Selank
    • Epithalon
  • Hormone Therapy
    • Testoterone Cypionate
  • Contact
  • More
    • Home
    • WHAT WE DO
    • GLPs
      • GLP-2, Tirzepatide
      • GLP-3, Retatrutide
    • Peptide Research
      • BPC-157
      • TB-500
      • Ipamorelin
      • Semorelin
      • Tesamorelin
      • CJC-1295 no DAC
      • MOTS-C
      • Semax
      • Selank
      • Epithalon
    • Hormone Therapy
      • Testoterone Cypionate
    • Contact
  • Home
  • WHAT WE DO
  • GLPs
    • GLP-2, Tirzepatide
    • GLP-3, Retatrutide
  • Peptide Research
    • BPC-157
    • TB-500
    • Ipamorelin
    • Semorelin
    • Tesamorelin
    • CJC-1295 no DAC
    • MOTS-C
    • Semax
    • Selank
    • Epithalon
  • Hormone Therapy
    • Testoterone Cypionate
  • Contact

Semax

Overview

 

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragments and has been studied for its potential cognitive and neuroprotective effects.

Research Interest Areas

  •  Cognitive function 
  • Focus and attention 
  • Neuroprotection 
  • Stress response

Proposed Mechanism

  •  Modulates neurotransmitter systems (dopamine, serotonin) 
  • May influence brain-derived neurotrophic factor (BDNF) 
  • Interacts with neurochemical signaling pathways

What the Research Suggests

 Human Studies:

  • Studied in certain neurological and cognitive contexts 
  • Observed improvements in attention and mental performance in some settings 

Preclinical Studies:

  • Neuroprotective effects 
  • Improved cognitive function in animal models

Evidence Summary

  •  Human Evidence: Limited to Moderate 
  • Animal Evidence: Moderate 
  • Mechanistic Support: Moderate 
  • Long-Term Safety: Limited

Limitations

 

  • Much of the research originates from Russia, but researched since the 80s. 
  • Not widely studied in large-scale Western clinical trials 
  • Long-term effects not well established

Key Takeaway

Semax is an emerging peptide in cognitive research, with promising early findings but still limited large-scale validation 

DISCLAIMER

 THIS CONTENT IS FOR EDUCATIONAL AND RESEARCH PURPOSES ONLY AND IS NOT INTENDED AS MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT.  

Copyright © 2026 Optimized Bio Consulting - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept